Environmental

JAGX appears neutral on environmental disclosure quality versus peers because the provided metrics do not show direct emissions, energy, or waste intensity advantages or gaps.

High R&D intensity relative to revenue can support lower-resource product innovation over time, but peers in regulated healthcare often disclose clearer environmental management practices.

No evidence provided of climate-risk governance, supply-chain environmental controls, or environmental targets, leaving JAGX broadly in line with smaller biotech peers rather than advantaged.

The absence of reported environmental incidents or remediation liabilities prevents a weaker score, yet limited disclosure keeps positioning below better-documented peer leaders.

Social

JAGX shows a mixed social profile because high gross margin and heavy R&D spending can support patient-focused innovation, but peer comparison is constrained by limited disclosure.

Stock-based compensation is modest relative to revenue, which can reduce employee-alignment concerns versus peers that rely more heavily on dilution-based incentives.

No workforce, safety, access, or product-responsibility metrics were provided, so JAGX cannot be judged as stronger than peers on core social execution.

Overall social positioning is moderate because the available data suggest some stakeholder alignment, but not enough transparency to outperform better-disclosed healthcare peers.

Governance

Governance is constrained by elevated debt-to-equity, which can increase oversight pressure and financing risk relative to peers with cleaner balance sheets.

Negative net debt to EBITDA suggests limited leverage stress, but the high debt-to-equity ratio still points to a weaker capital-structure profile than many peers.

Stock-based compensation is low versus revenue, which supports capital discipline, yet it does not offset the governance concern from leverage and limited disclosure.

Without board, audit, ownership, or controversy data, JAGX remains below stronger-governed peers because the available indicators do not show a clear governance advantage.

Overall Score

JAGX ranks as a moderate ESG performer versus peers because limited disclosure and leverage-related governance weakness outweigh the modest positives in capital discipline and innovation intensity.

Score Driver: Governance Is The Decisive Constraint, Driven By A Relatively High Debt-To-Equity Ratio And Insufficient Peer-Level Disclosure.